Treatment of manic or mixed episodes of up to moderate severity in patients with bipolar disorder and schizoaffective disorder. Non-interventional prospective cohort study (NIS) with Zeldox [ziprasidone]
Phase of Trial: Phase IV
Latest Information Update: 08 Jul 2015
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar I disorders; Bipolar II disorders; Schizoaffective disorder
- Focus Therapeutic Use
- Sponsors Pfizer
- 11 Jan 2008 Status changed from in progress to completed.
- 17 Sep 2007 Status changed from initiated to in progress.
- 14 Jun 2007 New trial record.